The share price is relatively high at this point....


I believe the top line results could come back positive but if they do not...the share price will drop like a rock. This is just a fact.


For a company with zero revenue and still some time before the drug is possibly in the pipeline, the share price is fairly priced.


Good luck to every one invested in this could prove to be the real deal...time will tell.